共 10 条
[1]
Assessment of brainnatriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data. Valli N,Georges A,Corcuff JB,et al. Clinica Chimica Acta . 2001
[2]
The B-type natriuretic peptide assay: a rapid test forheart failure. Peacock WF. Cleveland Clinic Journal of Medicine . 2002
[3]
Rapid bedsidemeasurement of brain natriuretic peptide in patients with chronicheart failure. Tjeerdsma G,de Boer RA,Boomsma F,et al. International Journal of Cardiology . 2002
[4]
Role of brain natriureticpeptide in the diagnosis and management of heart failure: currentconcepts. Latini R,Masson S,de Angelis N,et al. Journal of Cardiac Failure . 2002
[5]
Ultra-rapid measurement of brain natriuretic peptide. Logeart D. Archives des Maladies du Coeur et des Vaisseaux . 2002
[6]
Use of plasma brainnatriuretic peptide concentration to aid in the diagnosis of heartfailure. Shapiro BP,Chen HH,Burnett JC Jr,et al. Mayo Clinic Proceedings . 2003
[7]
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Richards AM,Nicholls MG,Espiner EA,et al. Circulation . 2003
[8]
Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. Sodian R,Loebe M,Schmitt C,et al. Journal of the American College of Cardiology . 2001
[9]
Diagnostic and prognosticusefulness of natriuretic peptides in emergency department patientswith dyspnea. Collins SP,Ronan-Bentle S,Storrow AB. Annals of Emergency Medicine . 2003
[10]
Brain natriuretic peptide-guided therapy for heart failure. Nicholls MG,Lainchbury JG,Richards AM,et al. Annals of Medicine . 2001